NEW YORK, NY -- (MARKET WIRE) -- January 25, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the Florida Cardiovascular Institute of Tampa, Florida.
